¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

Á¦4ȸ ´ëÇѼÒÈ­±âÇÐȸ °æ±âÀÎõÁöȸ ½ÉÆ÷Áö¾ö ¹× ¿¬±¸°úÁ¦ ¹ßǥȸ : 2024-07-20

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

Á¦4ȸ ´ëÇѼÒÈ­±âÇÐȸ °æ±âÀÎõÁöȸ ½ÉÆ÷Áö¾ö ¹× ¿¬±¸°úÁ¦ ¹ßǥȸ : 2024-07-20
±³À°ÀÏÀÚ : 2024-07-20
±³À°Àå¼Ò : °¡Å縯´ëÇб³ ¼ºÀDZ³Á¤ ¸¶¸®¾ÆȦ

±³À°ÁÖÁ¦ : Á¦4ȸ ´ëÇѼÒÈ­±âÇÐȸ °æ±âÀÎõÁöȸ ½ÉÆ÷Áö¾ö ¹× ¿¬±¸°úÁ¦ ¹ßǥȸ

ÁÖÃÖ±â°ü : ´ëÇѼÒÈ­±âÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇѼÒÈ­±âÇÐȸ °æ±â.ÀÎõÁöȸ

´ã´çÀÚ : À±Ã¤Çõ
¿¬¶ôó : 02-0000-0000

À̸ÞÀÏ : cmyk25@gmail.com

±³À°Á¾·ù : ³»°ú

Âü¼®¿¹»óÀÎ : 100¸í
Èñ¸ÁÆòÁ¡ : 4Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 4 ½Ã°£ 20ºÐ

¼¼ºÎ¼ö°­·á : 10,000¿ø  

ºñ°í


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±âŸ 07¿ù 20ÀÏ °¡Å縯´ëÇб³ ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 12:50~12:55 °³È¸»ç ±èº´¿í(´ëÇѼÒÈ­±âÇÐȸ °æ±â‧ÀÎõÁöȸ ȸÀå)

±âŸ 07¿ù 20ÀÏ °¡Å縯´ëÇб³ ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 12:55~13:00 Ãà»ç ±èÁÖ¼º(´ëÇѼÒÈ­±âÇÐȸ ÀÌ»çÀå)

±³À°½Ã°£ 07¿ù 20ÀÏ °¡Å縯´ëÇб³ ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 13:00~13:20 ÀÇ·á µ¿¿µ»óÀ» ÀÌ¿ëÇÑ ÀΰøÁö´É ¿¬±¸ »ç·Ê ±è±¤±â(°¡Ãµ´ë ±æº´¿ø ÀÇ°øÇаú)

±³À°½Ã°£ 07¿ù 20ÀÏ °¡Å縯´ëÇб³ ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 13:20~13:40 »ý¼ºÇü ÀΰøÁö´ÉÀÇ ÇöȲ°ú ÀÇ·á ºÐ¾ß Àû¿ë »ç·Ê Á¤±Ôȯ(¼º±Õ°ü´ë »ï¼ºÀ¶ÇÕÀÇ°úÇпø)

±³À°½Ã°£ 07¿ù 20ÀÏ °¡Å縯´ëÇб³ ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 13:40~14:00 Ãé´ãµµ ¿µ¿ª¿¡¼­ ÀÇ·á Àΰø Áö´ÉÀÇ ÀÀ¿ë ÃÖ¼ºÁö(ÇѾç´ëº´¿ø)

±³À°½Ã°£ 07¿ù 20ÀÏ °¡Å縯´ëÇб³ ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 14:00~14:20 ¿°Áõ¼º ÀåÁúȯ¿¡¼­ ÀΰøÁö´É ¿¬±¸ÀÇ ÃֽŠÁö°ß ±èÀ±Àç(ÀåÁÁÀº³»°ú)

±³À°½Ã°£ 07¿ù 20ÀÏ °¡Å縯´ëÇб³ ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 14:20~14:35 ¸¶ÀÌÅ©·Î¹ÙÀÌ¿È ±â¹Ý ÃéÀå¾Ï Áø´Ü ¹× ¿¹ÈÄ ¿¹Ãø ¹ÙÀÌ¿À¸¶Ä¿ °³¹ß¿¡ °üÇÑ ¿¬±¸ ÀÌÁ¤³²(ÀÎÇϴ뺴¿ø)

±³À°½Ã°£ 07¿ù 20ÀÏ °¡Å縯´ëÇб³ ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 14:35~14:50 Anti-inflammatory properties of hemostatic powder (UI-EWD) after endoscopic submucosal dissection (ESD) for nonpedunculated colorectal tumors ÀÌ¿ø¸í(¼øõÇâ´ë ºÎõº´¿ø)

±³À°½Ã°£ 07¿ù 20ÀÏ °¡Å縯´ëÇб³ ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 14:50~15:05 Ç÷û Æé½Ã³ë°Õ I/II¿¡ µû¸¥ À§Á¡¸· ¸¶ÀÌÅ©·Î¹ÙÀÌ¿ÈÀÇ ±¸¼º ±èº´¿í(°¡Å縯´ë ÀÎõ¼º¸ðº´¿ø)

±³À°½Ã°£ 07¿ù 20ÀÏ °¡Å縯´ëÇб³ ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 15:05~15:20 Comparison between transpapillary and suprapapillary metal stent placement with endoscopic sphincterotomy in common bile duct malignant obstruction: prospective randomized controlled study ÀåÀçÇõ(°¡Å縯´ë ºÎõ¼º¸ðº´¿ø)

ÈÞ½Ä 07¿ù 20ÀÏ °¡Å縯´ëÇб³ ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 15:20~15:30 Break ()

±³À°½Ã°£ 07¿ù 20ÀÏ °¡Å縯´ëÇб³ ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 15:30~15:45 Significance of 8-OHdG Expression as a Predictor of Survival in Colorectal Cancer ±èÁ¤È£(°¡Ãµ´ë ±æº´¿ø)

±³À°½Ã°£ 07¿ù 20ÀÏ °¡Å縯´ëÇб³ ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 15:45~16:00 Incidence and risk of pancreatic cancer in patients with chronic pancreatitis: Defining the optimal subgroup for surveillance ÀåÀçÇõ(°¡Å縯´ë ºÎõ¼º¸ðº´¿ø)

±³À°½Ã°£ 07¿ù 20ÀÏ °¡Å縯´ëÇб³ ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 16:00~16:15 Efficacy of tegoprazan-based bismuth quadruple therapy compared with bismuth quadruple therapy for Helicobacter pylori infection: A randomized, double-blind, active-controlled study ±èÁؼº(°¡Å縯´ë ÀÎõ¼º¸ðº´¿ø)

±³À°½Ã°£ 07¿ù 20ÀÏ °¡Å縯´ëÇб³ ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 16:15~16:30 ´Ù±â°ü ±Þ¼º ÃéÀå¿° ÄÚȣƮ¸¦ ÀÌ¿ëÇÑ ±Þ¼º ÃéÀå¿°ÀÇ ÅëÁõ Èıâ ÇÕº´Áõ (»ç¸Á ¶Ç´Â ½Ã¼ú ½ÃÇà) ¹ß»ýÀÇ Á¶±â ¿¹Ãø¿¡ °üÇÑ ¿¬±¸ °­È­Æò(°¡Ãµ´ë±æº´¿ø)

±³À°½Ã°£ 07¿ù 20ÀÏ °¡Å縯´ëÇб³ ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 16:30~16:45 º´¿ø°øÀ¯µ¥ÀÌÅ͸¦ ÀÌ¿ëÇÑ ¿ì¿¬È÷ ¹ß°ßµÈ ÀÛÀº ÃéÀ島Á¾ÀÇ ÀÚ¿¬»ç¿Í ¾Ç¼º ¿¹Ãø¿¡ °üÇÑ ¿¬±¸ ±èÈ¿¼®(°¡Å縯´ë ºÎõ¼º¸ðº´¿ø)

±³À°½Ã°£ 07¿ù 20ÀÏ °¡Å縯´ëÇб³ ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 16:45~17:00 ´ã°ü °á¼®À» Á¦°ÅÇÑ È¯ÀÚ¿¡¼­ ´ã°ü³» Á¾¾ç¼º º´º¯ÀÇ ¼±º°Áø´ÜÀ» À§ÇÑ ÀÏȸ¿ë ´ÜÀÏ-½Ã¼úÀÚ ´ãµµ³»½Ã°æÀÇ À¯¿ë¼º¿¡ °üÇÑ ¿¬±¸ ½ÅÀÏ»ó(¼øõÇâ´ë ºÎõº´¿ø)

±³À°½Ã°£ 07¿ù 20ÀÏ °¡Å縯´ëÇб³ ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 17:00~17:15 µÅÁö¸ðµ¨¿¡¼­ balloon-equipped light diffuser¸¦ ÀÌ¿ëÇÑ ÇϺΠ½Äµµ °ý¾à±ÙÀÇ ³»½Ã°æ ·¹ÀÌÀú Ä¡·á È¿°ú¿¡ °üÇÑ ¿¬±¸ Â÷º¸¶÷(ÀÎÇϴ뺴¿ø)

Åä·Ð 07¿ù 20ÀÏ °¡Å縯´ëÇб³ ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 17:15~17:30 Discussion ()

±âŸ 07¿ù 20ÀÏ °¡Å縯´ëÇб³ ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 17:30~17:50 ´ëÇѼÒÈ­±âÇÐȸ °æ±â‧ÀÎõÁöȸ Çмú»ó ¹× ¿¬±¸Çмú»ó ¼ö»óÀÚ ¹ßÇ¥ ±èÅÂÈ£(´ëÇѼÒÈ­±âÇÐȸ °æ±â‧ÀÎõÁöȸ Ãѹ«ÀÌ»ç)

±âŸ 07¿ù 20ÀÏ °¡Å縯´ëÇб³ ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ 17:50~18:00 Æóȸ»ç Á¤¼®(´ëÇѼÒÈ­±âÇÐȸ °æ±â‧ÀÎõÁöȸ ºÎȸÀå)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" Á¦4ȸ ´ëÇѼÒÈ­±âÇÐȸ °æ±âÀÎõÁöȸ ½ÉÆ÷Áö¾ö ¹× ¿¬±¸°úÁ¦ ¹ßǥȸ : 2024-07-20""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û 2024³â ´ëÇÑ°íÇ÷¾ÐÇÐȸ ´ë»çÁõÈıº¿¬±¸ ÇÏ°è ½ÉÆ÷Áö¾ö : 2024-07-20
´ÙÀ½±Û 2024³â ´ëÇÑ°í°üÀýÇÐȸ °üÀýº¸Á¸ ½ÉÆ÷Áö¿ò : 2024-07-20
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
21122 ¼­¿ï Çѱ¹¹é³»Àå±¼Àý¼ö¼úÇÐȸ 2024 KSCRS Annual Symposium(2ÀÏÂ÷) : 2024-07-14 0 115 2024-06-19
21121 ¼­¿ï Á¦8ȸ ÀüÀÓÀÇ Àü°øÀÇ °³¿øÀǸ¦ À§ÇÑ °£Áúȯ ¿¬¼ö°­Á : 2024-07-14 0 140 2024-06-19
21120 ¼­¿ï 24³âµµ ´ëÇѱâ´ÉÀÇÇÐȸ Çϰ迬¼ö°­Á : 2024-07-14 0 78 2024-06-19
21119 ¼­¿ï ´ëÇÑÇ÷°üÇÐȸ KOVAS 2024 Summer Conference (2ÀÏÂ÷) : 2024-07-13 0 139 2024-06-19
21118 ÀüºÏ 2024³â ´ëÇÑ»ý¹°Ä¡·áÁ¤½ÅÀÇÇÐȸ Çϰ迬¼ö±³À° : 2024-07-13 0 134 2024-06-19
21117 ¼­¿ï ´ëÇÑÁ·ºÎÁ·°üÀýÇÐȸ - Á¦1ȸ ´ç´¢¹ß ½ÉÆ÷Áö¾ö : 2024-07-13 0 62 2024-06-19
21116 ¼­¿ï õ½Ä¿¬±¸È¸ Workshop 2024 : 2024-07-13 0 63 2024-06-19
21115 ¼­¿ï 2024 Àç°ü·ùÄ¡·á¿¬±¸È¸ Ãá°è½ÉÆ÷Áö¿ò ¹× ÃÑȸ : 2024-07-13 0 152 2024-06-19
21114 ¼­¿ï Çѱ¹¹é³»Àå±¼Àý¼ö¼úÇÐȸ 2024 KSCRS Annual Symposium(1ÀÏÂ÷) : 2024-07-13 0 128 2024-06-19
21113 ¼­¿ï 2024 ´ç´¢º´½ÅÁõ ½ÉÆ÷Áö¾ö : 2024-07-13 0 53 2024-06-19
21112 ¼­¿ï ´ëÇÑÇ÷°üÇÐȸ KOVAS 2024 Summer Conference (1ÀÏÂ÷) : 2024-07-12 0 50 2024-06-19
21111 ¼­¿ï 2024 ´ëÇѽÅÃéÀåÀ̽Ŀܰú¿¬±¸È¸ ÇÏ°è Çмú´ëȸ : 2024-07-12 0 67 2024-06-19
21110 ¼­¿ï ´ëÇÑ¿ì¿ïÁ¶¿ïº´ÇÐȸ Çϰ迬¼ö±³À° : 2024-07-12 0 100 2024-06-19
21109 ¼­¿ï (¿Â¶óÀÎ) ´ëÇÑÁ¤Çü¿Ü°úÇÐȸ – Á¦5Â÷ Àå¾ÖÆÇÁ¤ ¿Â¶óÀÎ ½ÉÆ÷Áö¾ö : 2024-07-07 0 24 2024-06-19
21108 ¼­¿ï 2024³â ´ëÇѺñ´¢ºÎÀΰúÇÐȸ Á¦27Â÷ Çмú´ëȸ (¿ÀÇÁ¶óÀÎ) : 2024-07-07 0 121 2024-06-19
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷